N-(2-(5-chloro-2-methoxyphenylamino)-4'-methyl-4,5'-bithiazol-2'-yl)acetamide

ID: ALA4534844

Chembl Id: CHEMBL4534844

Cas Number: 333746-76-2

PubChem CID: 1144670

Max Phase: Preclinical

Molecular Formula: C16H15ClN4O2S2

Molecular Weight: 394.91

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(Cl)cc1Nc1nc(-c2sc(NC(C)=O)nc2C)cs1

Standard InChI:  InChI=1S/C16H15ClN4O2S2/c1-8-14(25-16(18-8)19-9(2)22)12-7-24-15(21-12)20-11-6-10(17)4-5-13(11)23-3/h4-7H,1-3H3,(H,20,21)(H,18,19,22)

Standard InChI Key:  AGTZTRPBFSCFQN-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4534844

    Mmp-9-IN-7

Associated Targets(non-human)

Taok2 Serine/threonine-protein kinase TAO2 (71 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.91Molecular Weight (Monoisotopic): 394.0325AlogP: 4.94#Rotatable Bonds: 5
Polar Surface Area: 76.14Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.98CX Basic pKa: 1.27CX LogP: 3.94CX LogD: 3.85
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.64Np Likeness Score: -2.09

References

1. Piala AT, Akella R, Potts MB, Dudics-Giagnocavo SA, He H, Wei S, White MA, Posner BA, Goldsmith EJ..  (2016)  Discovery of novel TAOK2 inhibitor scaffolds from high-throughput screening.,  26  (16): [PMID:27426302] [10.1016/j.bmcl.2016.07.016]

Source